复杂退行性疾病的无解题。β-淀粉样蛋白单抗再次失败！$罗氏控股(RHHBY)$

ACIU and Genentech Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease. 

Crenezumab did not statistically significantly slow or prevent cognitive decline .